VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $703,784,953 | +28.2% | 26,153,287 | +43.5% | 0.15% | +33.6% |
| Q2 2023 | $548,917,976 | -4.3% | 18,230,421 | +2.8% | 0.11% | -10.3% |
| Q1 2023 | $573,539,782 | +21.6% | 17,729,205 | +7.7% | 0.13% | +14.5% |
| Q4 2022 | $471,771,773 | +95.1% | 16,460,983 | +64.2% | 0.11% | +100.0% |
| Q3 2022 | $241,814,000 | -3.5% | 10,025,473 | +9.6% | 0.06% | -15.4% |
| Q2 2022 | $250,561,000 | -43.3% | 9,151,266 | -20.6% | 0.06% | -28.6% |
| Q1 2022 | $441,827,000 | +55.7% | 11,520,921 | +30.0% | 0.09% | +56.9% |
| Q4 2021 | $283,854,000 | -29.1% | 8,862,118 | -34.8% | 0.06% | -30.1% |
| Q3 2021 | $400,559,000 | -11.8% | 13,592,086 | +1.8% | 0.08% | -17.8% |
| Q2 2021 | $453,915,000 | +42.6% | 13,358,278 | +36.4% | 0.10% | +29.5% |
| Q1 2021 | $318,330,000 | -18.3% | 9,794,776 | -9.5% | 0.08% | -22.8% |
| Q4 2020 | $389,694,000 | -4.1% | 10,818,818 | +4.2% | 0.10% | -12.2% |
| Q3 2020 | $406,429,000 | +8.5% | 10,378,694 | +1.6% | 0.12% | -13.5% |
| Q2 2020 | $374,670,000 | +27.6% | 10,214,546 | -19.8% | 0.13% | +0.8% |
| Q1 2020 | $293,569,000 | -1.5% | 12,741,703 | +25.1% | 0.13% | +2.3% |
| Q4 2019 | $298,171,000 | -9.9% | 10,183,436 | -17.8% | 0.13% | -17.3% |
| Q3 2019 | $330,881,000 | +60.1% | 12,387,867 | +53.3% | 0.16% | +66.0% |
| Q2 2019 | $206,611,000 | +5.7% | 8,083,391 | -7.3% | 0.09% | -3.1% |
| Q1 2019 | $195,494,000 | +2.4% | 8,719,568 | -3.7% | 0.10% | -6.7% |
| Q4 2018 | $190,959,000 | +33.6% | 9,054,474 | +17.3% | 0.10% | +65.1% |
| Q3 2018 | $142,965,000 | +32.3% | 7,719,538 | +59.4% | 0.06% | +18.9% |
| Q2 2018 | $108,048,000 | -31.6% | 4,843,048 | -32.6% | 0.05% | -38.4% |
| Q1 2018 | $157,900,000 | +43.0% | 7,183,807 | +51.2% | 0.09% | +26.5% |
| Q4 2017 | $110,437,000 | -27.0% | 4,752,060 | -27.9% | 0.07% | -41.4% |
| Q3 2017 | $151,338,000 | -22.4% | 6,591,387 | -25.3% | 0.12% | -29.7% |
| Q2 2017 | $194,912,000 | +115.4% | 8,827,558 | +122.5% | 0.16% | +98.8% |
| Q1 2017 | $90,478,000 | -17.1% | 3,966,600 | -24.0% | 0.08% | -25.2% |
| Q4 2016 | $109,158,000 | +9.1% | 5,217,899 | +37.8% | 0.11% | +9.9% |
| Q3 2016 | $100,072,000 | +1587.0% | 3,786,272 | +1668.1% | 0.10% | +1342.9% |
| Q2 2016 | $5,932,000 | – | 214,140 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |